Here they are: Human-centric by design. The development and use of AI technologies align with ethical and human-centric values.Risk-based approach. The development and use of AI technologies follow a risk-based approach with proportionate validation, risk mitigation, and oversight based on the context of use and determined model risk.Adherence to standards. AI technologies adhere to relevant…
Maven Clinic launched a research institute to build and share evidence on the impact of digital care for women and families. The post What Maven Clinic Hopes to Achieve With Its New Research Institute appeared first on MedCity News.
Epic’s lawsuit against Health Gorilla is less about one alleged data misuse scheme and more about a deeper fault line in healthcare interoperability: data can move faster than the rules governing it. Experts say this problem could force the industry to redefine the boundaries of access, accountability and trust in data sharing. The post Epic…
People like Oprah Winfrey have struggled to maintain their weight loss after weaning themselves off GLP-1s. What if an outpatient medtech procedure did the trick? The post What if Oprah Knew About Fractyl Health? appeared first on MedCity News.
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
This policy watch discusses the implications for the U.S. health care workforce of the recent DOS immigrant visa pause for individuals from 75 countries deemed more likely to be a public charge.
Health-ISAC’s 2026 report warns of evolving threats like AI-driven attacks, sophisticated social engineering, and legacy device vulnerabilities
Tenpoint Therapeutics’ Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and AbbVie. Yuvezzi’s commercialization will be supported by up to $235 million in financing. The post Presbyopia Eye Drop From Startup Tenpoint Gets FDA Approval, Paving Way for $235M Financing…
In support of the WFTC legislation, CMS partners with tech firms to facilitate Medicaid community engagement
Silna Health’s solution evaluates whether clinical documentation meets payer requirements before a prior authorization is submitted